Affinity Investment Advisors, LLC
- SEC CIK
- 0001520601
- Latest filing
- Aug 5, 2026
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by Affinity Investment Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −8,886−100.0% | Sold out | Holders |
| Q4 2023 | 8,886 | $328.4K | 0.2% | −6,820−43.4% | Reduced | Holders |
| Q3 2023 | 15,706 | $600.0K | 0.4% | −480−3.0% | Reduced | Holders |
| Q2 2023 | 16,186 | $583.8K | 0.3% | −2,958−15.5% | Reduced | Holders |
| Q1 2023 | 19,144 | $731.1K | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 19,144 | $1.09M | 0.5% | −2,757−12.6% | Reduced | Holders |
| Q3 2022 | 21,901 | $866.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2022 | 21,901 | $964.0K | 0.5% | −930−4.1% | Reduced | Holders |
| Q1 2022 | 22,831 | $911.0K | 0.4% | −680−2.9% | Reduced | Holders |
| Q4 2021 | 23,511 | $945.0K | 0.4% | −485−2.0% | Reduced | Holders |
| Q3 2021 | 23,996 | $976.0K | 0.4% | +23,996 | New | Holders |